ALZAMEND NEURO, INC. Due to Related Parties, Current
ALZAMEND NEURO, INC. (ALZN) had Due to Related Parties, Current of $989.33 thousand as of 2022-10-31, per its 10-Q filed 2022-12-12.
Discontinued › Notes
us-gaap:DueToRelatedPartiesCurrent · last filed 2023-03-15
- 2022-10-31: Due to Related Parties, Current $989.33K.
- 2022-04-30: Due to Related Parties, Current $2.08K.
- 2022-01-31: Due to Related Parties, Current $2.08K.
- 2021-10-31: Due to Related Parties, Current $2.18K.
| Period end | Due to Related Parties, Current |
|---|---|
| 2022-10-31 | $989.33K 10-Q · filed 2022-12-12 |
| 2022-04-30 | $2.08K 10-Q · filed 2023-03-15 |
| 2022-01-31 | $2.08K 10-Q · filed 2022-03-15 |
| 2021-10-31 | $2.18K 10-Q · filed 2021-12-13 |
| 2021-07-31 | $60.75K 10-Q · filed 2021-09-13 |
| 2021-04-30 | $60.75K 10-K · filed 2022-07-19 |
| 2020-04-30 | $62.67K 10-K · filed 2021-07-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B |